Pharmaceutical research divisions are increasingly incorporating continuous wearable telemetry into late-stage clinical trials. Real-world data collection reduces patient burden while generating higher-resolution physiological datasets for analysis.
Regulatory Validation Pathways
Health regulatory bodies are establishing updated frameworks to evaluate algorithm-derived trial endpoints. Early adoption data suggests continuous monitoring can reduce required sample sizes by up to 15% without compromising statistical power.